| Omalizumab | Mepolizumab | Reslizumab | |
---|---|---|---|---|
Route | SC | SC | IV | IV |
Absolute bioavailability | 100% | 100% | – | – |
Tmax | 7–8 days | 4–8 days | End of infusion | End of infusion |
Vd | 78 mL/kg | 51 mL/kg | 55–85 mL/kg | ≈5 L |
CLS | 2.4 mL/kg/day | 3.1 mL/kg/day | 1.9–3.3 mL/kg/day | ≈7 mL/hour |
t½ | 26 days | 16–22 days | ≈20 days | ≈24 days |